treatment sessions and many treatments fail. Patients who failed APC in the past were treated with cryotherapy (cryo) requiring 3 sessions to show more effi cacy than APC. Endoscopic band ligation (EBL) has also been shown in small studies to be more eff ective than APC requiring on average 2 sessions for treatment. Antrectomy has been used as the defi nitive treatment when all else fails. Th e optimal treatment of this disease remains to be defi ned. Methods: We are presenting 2 cases of GAVE who failed other modalities but were successfully treated with the combination of EBL and cryo. Th e fi rst case is a 54-year-old man who was transferred to our medical center with ongoing bleeding from GAVE despite 6 Endoscopic treatment using APC. He required multiple bleeding related admissions over the preceding 3 months. His bleeding was compounded by anticoagulation because of high risk of embolization from mechanical mitral heart valve, CHF, Afi b and diabetes. We treated him with a combination of EBL in addition to cryo with CO2 to give him maximal benefi t in the shortest period of time. Th e patient had no recurrence of his bleeding and a follow-up upper endoscopy 5 weeks later showed signifi cant improvement in his GAVE. He has not required any blood transfusions for three months since his procedure despite being on Coumadin. Th e second patient had CHF and history of end stage renal disease on dialysis. He had GAVE with ongoing bleeding requiring multiple transfusions. His GAVE was treated in 2 years with 2 sessions of APC, then with Halo 90, then a session of cryo, then 2 sessions of EBL, then 2 cryo sessions and his hemoglobin was still 7.1. We treated him with the combination of EBL and cryo 2 sessions three weeks apart. He became transfusion free and his hemoglobin 2 months later was 14.7. Results: EBL advantage is obliteration of the deep mucosal and submucosal plexuses as compared to the mucosal only eff ect of APC. Its eff ect is however localized. Cryo complements EBL because of the diff use action also involving both the mucosa and the submucosa. Combining these modalities in the thick gastric antrum where the complication risk is minimized was safe and highly eff ective in these patients who failed multiple other treatments. Conclusion: Th e combination here gave a dramatic synergistic eff ect with a faster onset of action. RCTs are warranted.
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Purpose: Tumor related GI bleeding (GIB) is a common and challenging clinical problem in patients with cancer. Argon plasma coagulation (APC) is one of the endoscopic hemostatic methods preferred for the management of nonneoplastic causes of GIB. However limited information is available on its role in management of bleeding GI tumors. Th e aim of this study was to assess the role of APC in the management of bleeding GI tumors. Methods: We performed a retrospective review of all endoscopies done at the UT MD Anderson Cancer Center over 3 consecutive years (2009-2011) and identifi ed cases of tumor related gastrointestinal bleeding treated by APC. We collected data regarding demographics, cancer diagnosis and treatment, routine laboratory tests, outcomes of APC treatment, complications, and overall survival. Results: Argon plasma coagulation (APC) was performed on 10 patients with a median age of 58 (20-67) years. Majority of the patients were Caucasians (90%) and were male (80%). Th e diagnoses included 3 (30%) cases of esophageal cancer, 2 (20%) cases of colorectal cancer, and 1 (10%) case of each, gastric adenocarcinoma, gastrointestinal stromal tumor, renal cell cancer, multiple myeloma and large B cell lymphoma. Four patients presented with hematemesis (40%), four had melena (40%) and two presented with hematochezia (20%). Metastatic disease was present in all (100%) patients, with intraabdominal metastasis in 90% and intrathoracic metastasis in 60% of patients. APC was performed either alone (7 patients) or with adjuvant epinephrine (3 patients). Immediate hemostasis was achieved was in all 10 (100%) patients. None of the patients developed any procedure related complications. Four patients (40%) required blood transfusion within 48 hours of the procedure. Re-bleeding happened in 3 (30%) patients during follow up. at 48 hours, at 72 hours and at 1 year in 1 patient each. One patient was managed by conservative treatment with blood transfusion only; while 2 patients underwent intervention radiology guided embolization therapies. Median time between procedure to discharge was 5 (Range: 1-106) days. 30 day mortality rate was 0%. Mortality occurred in 8 (80%) patients over a mean follow-up of 262 (range: 46-805) days. Th e median time to mortality was 131 (95% CI: 59-176) days. Total of 7 (70%) of patients were able to continue cancer specifi c therapy including chemotherapy, radiation or both. Conclusion: In our experience, APC is feasible and safe in routine practice to manage bleeding GI tumors with procedure related complication rate of 0%. It is very eff ective in achieving initial hemostasis (100%) and allows majority of the patients (70%) to undergo cancer specifi c therapy.
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Start Up: Opening a Gastroenterology Lab in a Field Hospital in Port au Prince Richard McGlaughlin, MD, 2 Nathalie Colas, MD 1 . 1. Gastroenterology, St Luc's Hospital, Port auPrince, Haiti; 2. St Vincent's Hospital, Birmingham, AL. Purpose: In the 2010 earthquake in Port au Prince, the medical school was crushed. Many faculty and students were killed. St. Damien's Pediatric Hospital was overloaded with adult trauma patients. A fi eld hospital was created. It expanded to become an acute care adult hospital, later named St Luc's. Th e cholera epidemic began in October, 2010, and St Luc's hospital became a permanent structure. 30,000 cholera patients have been treated there, with a mortality rate of 1.4%. A review of the fi rst six months' admissions revealed pyrosis and or dyspepsia as a primary or secondary diagnosis in 48% of patients. Discharge diagnoses were similar, with pyrosis and dyspepsia listed 45% of the time. A gastroenterology lab was created in one of the containers to study this. Th is report describes the fi rst two hundred endoscopies performed there. Methods: Portable O 2 saturation monitors, and pre-and postoperative pulse and blood pressure, and sedation with midazolam, meperidine, and benzocaine spray. Path specimens were studied at St. Vincent's Hospital and UAB Medical West in Birmingham, and Bessemer, AL. Results: Indications for endoscopy included pain, poor response to therapy, bleeding, unexplained anemia, and weight loss. 143 women and 57 men, of ages of 17 and 88 were endoscoped, including 65 inpatients and 135 outpatients. 67 endoscopies were normal. RUT tests were concordant with histology in 95%. Helicobacter pylori was found in 58%, with (36%) or without (64%) gastric or duodenal ulcers. Nine gastric cancers were seen: six were Helicobacter positive. Five patients had esophageal varices, banded without complication. Five patients had achalasia, one was familial. All were treated without complication. One patient required reversal of sedation. Conclusion: RUT and histology are concordant. Helicobacter responded well to antibiotic treatment (MOA-Pepto). Nine gastric cancers were seen. Th e achalasic patients were unexpected. Chaga's disease, clinically similar to achalasia, is not described in Haiti. Treatment regimens changed for about 65%, based on the endoscopic fi ndings. 34% of endoscopies were normal. Complications were infrequent. In the future, portable sonography should result in a greater diagnostic yield. Helicobacter breath testing would useful to follow the treated HP patients. Th e surprising number of achalasics will require further study. Th is lab was assembled from used equipment bought cheap or donated. Repair costs for this equipment are prohibitive, and the expertise required for repair is not available in Port au Prince. Th is may limit the long term viability of the lab. the ciliary muscle of the eye, the heart and blood vessels, and the central nervous system, are both anticholinergic agents. Atropine is oft en used to treat bradycardia during a variety of medical procedures, including endoscopies, ECT, and bronchoscopies. Unfortunately, it has the signifi cant adverse eff ect of causing refl ex tachycardia. Glycopyrrolate has been compared to atropine in studies of procedures including laryngoscopy and bronchoscopy. No studies have been done comparing the two in gastrointestinal (GI) procedures. Th e purpose of this study was to determine the frequency of use of glycopyrrolate versus atropine for bradycardia by gastroenterologists and anesthesiologists during routine colonoscopy. Methods: An online survey was sent to 2,222 gastroenterologists and anesthesiologists throughout the United States. Information obtained from the survey included years spent in practice, heart rate at which a drug intervention was generally administered, which drug was administered and the dose the drug was usually administered. Results: Of the 169 respondents, 35 (21%) were Anesthesiologists and 134 (79%) were gastroenterologists. Th e majority of respondents (65%) had been in practice for over 10 years. 76% of respondents administered drug treatment for bradycardia at a heart rate less than 40 with about 78% of respondents using atropine. Only 8 anesthesiologists (25%) consider using atropine. Of the 24 anesthesiologists who did not use atropine, 22 (92%) indicated using glycopyrrolate. Of the gastroenterologists, only 9 (7%) indicated using a drug other than atropine. Conclusion: While gastroenterologists use atropine as the main drug intervention for bradycardia, Anesthesiologists more frequently utilize other drugs, including glycopyrrolate. Based on the results of this study, we believe that further studies into the use of atropine and glycopyrrolate use for the treatment of bradycardia during routine colonoscopy is warranted.
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Application of the SPICE Criteria to Previously Seen Low Risk Bulges: Results from the University of California Irvine Capsule Endoscopy Database
William Nguyen, MD. University of California Irvine, Irvine, CA.
Purpose: Small bowel capsule endoscopy is a useful tool for the evaluation of obscure gastrointestinal bleeding, suspected Crohn's disease or small bowel malignancies. Th e most common unexplained fi nding on capsule endoscopy is visible luminal bulges. Th ese bulges can be categorized as high risk by having features such as bleeding, mucosal disruption, irregular surface, or polypoid appearance. Low risk bulges oft en present as smooth, round protrusions with ill defi ned boundaries but may be mistaken for submucosal malignant masses. Th e recently published Smooth, Protruding lesion Index on Capsule Endoscopy (SPICE) criteria helps to diff erentiate which low risk bulges need further investigation. Our aim is to review our capsule database to determine if our clinical decision on low risk bulges would have changed with the new SPICE criteria. Methods: We retrospectively reviewed all available capsule endoscopy studies between 2002-2009 from the University of California Irvine Capsule database. All complete capsule studies with previously reported low risk bulges were included. We reviewed the videos of each bulge and applied the SPICE criteria [(1) ill-defi ned boundary (2) diameter >height (3) nonvisible lumen (4) image lasting 10 minutes] to each bulge with a score of 0-4. Results: 604 capsule reports were reviewed. Th ere was an overall incidence of n=150 (24.7%) for fi nding bulges with n=137 (91.3%) of those bulges categorized as low risk. 64 videos of low risk bulges were available to be reviewed. All low risk bulges reviewed had a SPICE score that ranged from 0-2 with no bulge having a score >2. Conclusion: In our experience, bulges were seen in 25% of capsule studies with 91.3% of those bulges previously categorized as low risk. All of the previously reviewed low risk bulges had a SPICE score of less than 3 indicating these low risk bulges are likely innocent bulges. Our clinical decision would not have changed in any of the cases reviewed by using the SPICE criteria. Felix Leung, MD, FACG. Sepulveda Ambulatory Care Center, VAGLAHS and David Geff en School of Medicine at UCLA, North Hills and Los Angeles, CA. Purpose: Th is systematic review assesses developments in water-aided methods for colonoscopy. Methods: A Medline search (publications) and a Clinicaltrial.gov search (registered RCT) of water-aided methods were carried out (1999 to 2011). E-mail communications with investigators around the world provided updates of ongoing trials. Results: Figure 1 shows there is a progressive increase in the number of published reports (RCT, observational studies, case series, reviews and editorials), RCT registered with Clinicaltrial.gov, and funded projects in North America and overseas. A. RCT (vs. air) (total N: male 1,752, female 638) reveal: 1. All except 2 RCT showed a signifi cant reduction of pain during colonoscopy (Table 1 A). Reduced pain was associated with increased patient satisfaction. 2. Water exchange (exclusion of all air and removal of infused water predominantly during insertion to clear debris [salvage cleansing] and minimize distention [pain avoidance]) is more eff ective than water immersion (adjunct to air and infused water removed predominantly during withdrawal) in minimizing insertion pain (Table 1B) . Th e latter was associated with impaired view. 3. Water exchange alone (Table 2 ) or in combination with indigocarmine signifi cantly increases adenoma detection. 4. Less need for compression and shorter recovery time with water exchange generated support staff buy-in. B. Observational studies suggest water-aided methods identify bleeding sites, enhance cecal intubation in diffi cult (previously failed) colonoscopy, increase adenoma detection when combined with cap-assisted colonoscopy, detort sigmoid volvulus, permit underwater polypectomy and submucosal dissection, enforce salvage cleansing even with split dose regimen. C. Self-training is feasible; but structured coaching and practice expedite acquisition of the skills necessary to implement water exchange. D. Important ongoing RCT are focused on diffi cult colonoscopy, adenoma detection, pain-alleviation (with CO 2 insuffl ation), completion of extended fl exible sigmoidoscopy and comparison of air vs. immersion vs. exchange. Conclusion: Old dogs (established colonoscopists) are learning new tricks (water-aided methods). Th e plethora of reports and ongoing trials demonstrates interests in this approach which may have immense implications in advancing patient-centered care. 
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Old Dogs Are Learning New Tricks: A Systematic Review of Evolving Interests in Water-aided Methods for Colonoscopy
Water-aided methods for colonoscopy
Number of RCT of Air vs. Water-aided Methods
Impact of Water Immersion or Exchange on ADR
